CIPLA
-

Fight for cheaper HIV drugs: The extraordinary stories of an Indian and a South African
Harsh Mander
-

Coronavirus: Moderna vaccine gets approval for restricted emergency use in India
Scroll Staff
-

Coronavirus: India eases norms for clearing foreign-made vaccines, Pfizer, Cipla likely to benefit
Scroll Staff
-

Coronavirus: Cipla, Roche launch antibody cocktail in India at Rs 59,750 per dose
Scroll Staff
-

Coronavirus: Maharashtra, Delhi in list of five states to get first set of remdesivir drug
Scroll Staff
-

New Year smiles: As firecrackers burst at Priyanka Chopra wedding, social media saw hypocrisy shine
Anirudh A Ashar
-

To reduce impact of GST on medicines, NPPA notifies new prices for 761 drugs
Scroll Staff
-

In the news: New ‘test and treat’ HIV policy, Cipla vs the pharma pricing regulator and more
Scroll Staff
-

Centre sources out-of-stock HIV drug through global agency, starts paying Cipla its dues: The Hindu
Scroll Staff
-

An HIV medicine for toddlers is out of stock across India
Menaka Rao
-

637 HIV+ people write to Centre asking it to pay Cipla for life-saving drug
Scroll Staff
-

Is 74% foreign direct investment in brownfield pharma really bad for Indian generics?
Prashant Reddy
-

The new pharma FDI policy undermines Indian generics, which may make drugs more expensive
Leena Menghaney
-

Scroll.in stories you may have missed this week
Scroll Staff
-

How the romance between an Aligarh Muslim and a Lithuanian Jew has shaped an Indian pharma major
Kenneth X. Robbins and John Mcleod